Sperling Prostate Center

Tag: Prostate cancer

What Transrectal Ultrasound Can’t Do

An Important Update on the Rise in Post-Biopsy Infections
When multiparametric MRI goes head-to-head against transrectal ultrasound (TRUS), it continues to demonstrate clear seniority in detecting clinically significant prostate cancer. Although conventional grayscale ultrasound can provide better results when combined with additional power using b-mode or Doppler USS, newer technologies continue to be developed. These include... keep reading

7 Ways to Make Active Surveillance Monitoring More Trustworthy

For the right prostate cancer (PCa) patient, Active Surveillance (AS) is a good thing. Urologic professionals now see eye-to-eye on monitoring with a focus on “preventing overtreatment in patients for whom the benefit of treatment deferral outweighs the need for immediate oncologic control.”[i] That’s a technical way of saying, if you don’t have clinically significant keep reading
WordPress Image Lightbox